Author

Haley Elizabeth Ramsey

Vanderbilt UniversityORCID 0009-0007-1201-250XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Agnieszka E. GorskaiD· 2 shared Michael Robert SavonaiD· 2 shared Sarah D. OlmsteadiD· 2 shared Alexander James SilveriD· 1 shared Anand Kamal SinghiD· 1 shared Andrew J. MonteithiD· 1 shared Anna SkwarskaiD· 1 shared Benjamin J. ReismaniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Agnieszka E. GorskaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 13, 2026

Specific F1 ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemia

Matthew T. Villaume, Haley Elizabeth Ramsey, Valeria Impedovo…·Michael Robert Savona

This study shows that inhibiting F1 ATP synthase with EB2023 causes transient mitochondrial stress in AML cells, enabling effective treatment without harming healthy tissues.

DOI 10.64898/2026.07.10.737821

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyGenePeer-reviewedApr 11, 2025

Repair of leukemia-associated single nucleotide variants via interallelic gene conversion

Alexander James Silver, Donovan J. Brown, Sarah D. Olmstead…·Michael Robert Savona

This study demonstrates that CRISPR-mediated interallelic gene conversion can revert heterozygous SNVs in leukemia cells without exogenous templates, improving survival in xenograft models.

4 citations

humanwhole-genome sequencing

𝕏 PostBluesky